AustinPx
PrivateLast Round
Series C
Oct 16, 2020
Total Funding Raised
$53.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AustinPx operates in Healthcare & Life Sciences and is based in Georgetown, Texas. Its latest recorded funding round was a Series C round in October 2020.
AustinPx is a pharmaceutical services company that provides contract development and manufacturing organization (CDMO) services, specializing in bioavailability enhancement and oral dosage form development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AustinPx Comparables
Compare AustinPx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ascendia | 88% | |
| Ascendia Pharmaceutical Solutions | 88% | |
| Serán Bioscience | 85% |
For institutional investors. Book with your work email.
AustinPx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 16, 2020 | ||||
| Early Funding | Apr 26, 2018 | ||||
| Early Funding | Nov 9, 2016 | ||||
| Early Funding | Feb 3, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AustinPx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 253% MoM, reaching 7K.
- Apr 26, 2018
$27M raised, led by Research Corporation Technologies.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 16, 2026
On Sep 16th '26 in Texas, AustinPx, LLC.'s KinetiSol(TM) Technology receives the FDA's Advanced Manufacturing Technology designation from the Center for Drug Evaluation and Research, supporting earlier FDA engagement and greater regulatory predictability for drug developers.
For institutional investors. Book with your work email.
AustinPx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AustinPx's valuation, stock price, and market status.
Is AustinPx a public or private company?
AustinPx is a private company.
What is the current stock price of AustinPx?
AustinPx is a private company, so its shares have no public market price. Caplight tracks AustinPx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AustinPx worth (valuation)?
Valuation information for AustinPx is not publicly available.
Can I buy AustinPx stock?
AustinPx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AustinPx's last funding round?
AustinPx's most recent funding round was Series C on October 16, 2020.
Who are the main investors in AustinPx?
Key investors in AustinPx include Research Corporation Technologies.
Will AustinPx IPO soon?
No public IPO plans have been announced for AustinPx.
How can I track AustinPx secondary market activity?
Caplight tracks bids, offers, and trades in AustinPx's shares on secondary markets.